QuiVad

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on August 11, 2026.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 8.43% on August 19, 2021. The shaded band is the year shown above.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.30%newAugust 11, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

History of disclosures

437 disclosures on record for this share.
DateFund% of capitalEnd of publication
September 20, 2022Point72 Asset Management LP0.91%still open
September 19, 2022Voleon Capital Management LP2.03%still open
September 14, 2022Voleon Capital Management LP1.90%still open
September 9, 2022Voleon Capital Management LP1.85%still open
September 1, 2022Voleon Capital Management LP1.74%still open
August 26, 2022Voleon Capital Management LP1.69%still open
August 24, 2022Voleon Capital Management LP1.52%still open
August 23, 2022Voleon Capital Management LP1.45%still open
August 22, 2022Voleon Capital Management LP1.30%still open
August 19, 2022Voleon Capital Management LP1.23%still open
August 18, 2022Voleon Capital Management LP1.03%still open
August 17, 2022Voleon Capital Management LP0.94%still open
August 16, 2022Voleon Capital Management LP0.80%still open
August 15, 2022Voleon Capital Management LP0.72%still open
August 12, 2022Voleon Capital Management LP0.68%still open
August 10, 2022Voleon Capital Management LP0.57%still open
June 21, 2022Voleon Capital Management LP0.00%still open
June 20, 2022Voleon Capital Management LP0.56%still open
June 17, 2022Voleon Capital Management LP0.68%still open
June 16, 2022Voleon Capital Management LP0.91%still open
June 15, 2022Voleon Capital Management LP1.00%still open
June 14, 2022Voleon Capital Management LP1.11%still open
June 13, 2022Voleon Capital Management LP1.20%still open
June 10, 2022Voleon Capital Management LP1.54%still open
June 8, 2022Voleon Capital Management LP1.67%still open
June 7, 2022Voleon Capital Management LP1.78%still open
June 3, 2022Voleon Capital Management LP2.15%still open
May 30, 2022Voleon Capital Management LP2.20%still open
May 19, 2022Voleon Capital Management LP2.15%still open
May 11, 2022Voleon Capital Management LP2.21%still open
May 6, 2022Voleon Capital Management LP2.14%still open
May 2, 2022Voleon Capital Management LP2.07%still open
April 26, 2022Voleon Capital Management LP2.18%still open
April 21, 2022Voleon Capital Management LP2.35%still open
April 19, 2022Voleon Capital Management LP2.59%still open
April 13, 2022Voleon Capital Management LP2.60%still open
April 12, 2022Voleon Capital Management LP2.59%still open
April 11, 2022Voleon Capital Management LP2.47%still open
April 8, 2022Voleon Capital Management LP2.39%still open
April 7, 2022Voleon Capital Management LP2.03%still open
April 6, 2022Voleon Capital Management LP1.60%still open
April 5, 2022Voleon Capital Management LP1.44%still open
April 5, 2022GSA Capital Partners LLP0.00%still open
April 4, 2022GSA Capital Partners LLP0.50%still open
April 1, 2022GSA Capital Partners LLP0.68%still open
March 31, 2022GSA Capital Partners LLP0.87%still open
March 30, 2022GSA Capital Partners LLP1.04%still open
March 29, 2022GSA Capital Partners LLP1.23%still open
March 28, 2022GSA Capital Partners LLP1.40%still open
March 25, 2022Voleon Capital Management LP1.39%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/oncopeptides-ab?page=3